GTX (GTXI) Soars After Analyst Highlights Prostate Cancer Drug, Upgrades to Buy
Go back to GTX (GTXI) Soars After Analyst Highlights Prostate Cancer Drug, Upgrades to Buy| GTX, Inc. (NASDAQ: GTXI) | Delayed: 1.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.20 | 52 Week High | $1.12 | |||
| Open | $24.29 | 52 Week Low | $0.32 | |||
| Day High | $1.20 | P/E | N/A | |||
| Day Low | $1.20 | EPS | $-0.75 | |||
| Volume | 202 | |||||

